AI Article Synopsis

  • The study measured the activity of five lysosomal marker enzymes in patients with acute myocardial infarction (AMI) and unstable angina pectoris (UAP) to assess disease severity.
  • Significant increases in enzyme activity were observed on the first day of hospitalization for both conditions, with levels being higher in patients with more severe AMI.
  • Clinical improvement correlated with decreased enzyme activity by days 7-10, while persistently high enzyme levels indicated worsening conditions, suggesting that lysosomal enzyme tests could help differentiate between AMI and UAP and predict disease recurrences.

Article Abstract

Serum activity of five lysosomal marker enzymes was measured in patients with acute myocardial infarction (AMI) and unstable angina pectoris (UAP) with consideration of the disease severity. A significant increase of enzyme activity was found both in patients with UAP and AMI on the first day of hospitalization. The enzymes activity was higher in patients with more severe form of AMI. Lysosomal enzyme activity was closely related to severity of the disease: clinical improvement occurred in patients with decreased activity (on day 7-10), while in aggravation of the disease lysosomal hyperenzymemia stayed high up to the end of the observation period (on day 30). The above findings demonstrate feasibility of using lysosomal enzymes test both for differentiation between AMI and UAP and for predicting the disease recurrences.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patients acute
8
acute myocardial
8
enzyme activity
8
activity
6
lysosomal
5
patients
5
[the diagnostic
4
diagnostic prognostic
4
prognostic assessment
4
assessment changes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!